Live from the NIH registry
Studies recruiting near Wilmington right now
Top 25 of 109 recruiting studies, sorted by proximity — each links to its official registry page
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
PMG Research — Wilmington, North Carolina (3.8 mi)
· Sponsor: Duke University
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Erosive Esophagitis, Heartburn
N/A
Observational 728 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: Phathom Pharmaceuticals, Inc.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Accellacare and KDCILM, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Novant Health Cancer Institute Radiation Oncology - Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: NRG Oncology
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Accellacare of Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Amgen
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
Phenylketonuria, Maternal
N/A
Observational 50 participants sought
Syneos Health — Wilmington, North Carolina (3.8 mi)
· Sponsor: BioMarin Pharmaceutical
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
N/A
Observational 200 participants sought
PPD Virtual — Wilmington, North Carolina (3.8 mi)
· Sponsor: argenx
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Wilmington Health, PLLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
PMG Research of Wilmington LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Acne Scars
Phase 3
Interventional 395 participants sought
Wilmington Dermatology Center /ID# 256192 — Wilmington, North Carolina (3.8 mi)
· Sponsor: AbbVie
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
PPD Virtual - PPD - US — Wilmington, North Carolina (3.8 mi)
· Sponsor: Bristol-Myers Squibb
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Multiple Sclerosis
N/A
Observational 728 participants sought
BRIUMVI® Pregnancy Registry Virtual Research Coordination Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: TG Therapeutics, Inc.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Accellacare Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
Phase 3
Interventional 300 participants sought
Accellacare Research of Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Amgen
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
Osteoarthritis (OA) of the Knee
Phase 2
Interventional 135 participants sought
M3 Wake Research - Wilmington, NC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pacira Pharmaceuticals, Inc
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Pregnancy Related, Pregnancy Complications
N/A
Observational 728 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Relapsing Multiple Sclerosis
N/A
Observational 16 participants sought
PROVIDE Virtual Research Coordination Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: TG Therapeutics, Inc.
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Innovo Research - Wilmington Gastroenterology Associates — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Carolina Arthritis Associates - Cliniverse Research (Network) — Wilmington, North Carolina (3.8 mi)
· Sponsor: Elevara Medicines Limited
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Obesity
Phase 2
Interventional 230 participants sought
KDCILM, LLC & Accellacare US, Inc. — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Obesity, Overweight
Phase 2
Interventional 300 participants sought
Accellacare-Wilmington-67123 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Boehringer Ingelheim
Prevail Global Study
Coronary Artery Disease
N/A
Interventional 1,205 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Medtronic Vascular